The clinical research to evaluate the efficacy of landiolol on cardiac function in patients with acute heart failure

The clinical research to evaluate the efficacy of landiolol on cardiac function in patients with acute heart failure - Landiolol study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004342

Enrollment

Registered

2010-10-15

Start date

2010-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) age:20-80 yaearts old 2)patients who admitted to CCU 3)EF<35% 4)HR>90bpm 5)NYHA III-IV

Exclusion criteria

Exclusion criteria: The exclusion criterion was a systolic blood pressure below 80 mmHg.

Design outcomes

Primary

Measure	Time frame
1)To evaluate the effect of landiolol on hemodynamics by cardiac catherization 2)To investigate change of indeces of cardiac function by echocardiography	—

Secondary

Measure	Time frame
We recorded any adverse events that occurred during the administration of landiolol, such as hypotension (defined as systolic arterial pressure <60 mmHg), angina, electrocardiographic evidence of ischemia, acute renal failure, dyspnea, or arrhythmia. We also noted the clinical outcome for each patient.	—

Countries

Japan

Contacts

Public ContactShigeki Kobayashi

Yamaguchi University Department of Medicine and Clinical Science

0836-22-2248

Outcome results